Proteimax discovers and commercializes biologically active peptides. Its mission is to solve some of the most pressing problems of humanity, ranging from chronic disease to food loss. Proteimax was born in its discovery of a new class of peptides. Among them is a decapeptide produced in fat cells that flattens glycemic spikes, reduces fasting insulin, and promotes loss of body fat. This peptide is envisioned as a functional ingredient for a completely new, food based approach to the global epidemic of obesity and diabetes. The Proteimax peptide bank contains 54 members representing vast commercial potential. The company is seizing this potential sequentially, starting with the anti-obesity food additive. The company operates out of Rehovoth, Israel and Miami, Florida.